Nazative Nasal Spray (Mometasone Furoate (Unformulated))

Adult use

For allergic rhinitis, adults should spray twice in each nostril once daily (total daily dose 0.2 mg). If symptoms are alleviated, the dose may be reduced to once in each nostril once daily (total daily dose 0.1 mg). If symptoms are not alleviated, the number of sprays may be increased to a maximum of 4 sprays in each nostril once daily (total daily dose 0.4 mg), and it's recommended to reduce the dose when symptoms decrease. For nasal polyps, generally, spray twice in each nostril once daily (total daily dose 0.2 mg). If symptoms do not improve after 5 to 6 weeks, the dose may be increased to twice a day by spraying twice in each nostril (total daily dose 0.4 mg), and it is recommended to reduce the dose when symptoms improve. If there is no symptom alleviation after 5 to 6 weeks of twice-a-day administration, consider alternative therapies. There have been no studies on the use of this medication for more than 4 months for the treatment of nasal polyps. For acute sinusitis, generally, spray twice in each nostril twice daily (total daily dose 0.4 mg).

Child use

For allergic rhinitis, children aged 2 to 11 years should spray once in each nostril once daily (total daily dose 0.1 mg).

This medication should not be used in certain patients. For instance, individuals who are allergic to this drug or its components, those with untreated infections of the nasal mucosa, those who have recently undergone nasal surgery or have nasal trauma, and infants under 2 years of age should not use this medication. Care should be taken when using this medication for patients with respiratory tuberculosis or systemic infections, those with recurrent nosebleeds, individuals at risk of exposure to chickenpox or measles, patients with certain kinds of nasal polyps, and pregnant or breastfeeding women should use it cautiously after consulting a physician. Potential side effects of this medication include headaches, viral infections, pharyngitis, nosebleeds, cough, upper respiratory tract infections, and in some patients, allergic reactions or symptoms of nasal mucosal irritation may occur. Rarely, severe allergic reactions such as anaphylaxis may occur, so if unusual symptoms appear, discontinue use immediately and consult medical staff. Long-term use at high doses can lead to systemic corticosteroid side effects, so caution is needed. Additionally, the use of this medication should be stopped or appropriate treatment may be necessary if nasal infection symptoms occur. Patients receiving this medication should have their nasal mucosal condition checked regularly, and especially for children, growth rates should be periodically monitored as it may affect growth. Pregnant or breastfeeding women should consider the potential risks and benefits of using this medication, and corticosteroid use during pregnancy should be closely monitored for signs of adrenal insufficiency in newborns. Moreover, this medication may interact with other drugs, particularly in patients taking CYP3A4 inhibitors, as the risk of side effects may increase; caution is advised when used in combination. When using, shake the container well, and perform a test spray if using for the first time or after not being used for a long time to ensure uniform spraying. This medication should only be sprayed into the nasal cavity and care should be taken to avoid direct spraying into the eyes or the nasal septum. Finally, keep this medication out of reach of children and the effects on driving or operating machinery are not known.

Serious side effects

Hives, severe swelling (edema), difficulty breathing, symptoms of anaphylaxis (difficulty breathing, angioedema, hives, etc.), nosebleeds, generalized flushing, severe allergic reactions, severe skin reactions, bronchospasm, breathing difficulties, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, liver abnormalities (elevated jaundice-related levels), visual disturbances, serious neurological symptoms (headaches, confusion, paralysis).

Mild side effects

• Headaches
• viral infections
• pharyngitis
• nosebleeds/blood-stained mucus
• cough
• upper respiratory tract infections
• menstrual pain
• musculoskeletal pain
• sinusitis
• vomiting

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is recommended to maintain a storage temperature between 2 and 25 degrees Celsius. Proper storage will help maintain the medication's efficacy and safety.

Appearance

A cloudy suspension that is white or nearly white, packaged in a container that dispenses a specific amount.

Package unit

18g/bottle